zaprinast and cicletanine

zaprinast has been researched along with cicletanine* in 1 studies

Other Studies

1 other study(ies) available for zaprinast and cicletanine

ArticleYear
Zaprinast, cicletanine, and verapamil attenuate overdrive pacing-induced myocardial ischemia in conscious rabbits.
    Life sciences, 1993, Volume: 53, Issue:1

    In conscious rabbits equipped with right ventricular electrode and left ventricular polyethylene catheters, zaprinast and cicletanine, inhibitors of phosphodiesterase (PDE) V and PDEs I and V, respectively, as well as verapamil, a Ca2+ channel blocker, decreased intracavital ST-segment elevation induced by ventricular overdrive pacing (VOP). Zaprinast and cicletanine attenuated VOP-induced QT reduction and increase in left ventricular end-diastolic pressure (LVEDP), whereas verapamil increased LVEDP. These results suggest that inhibition of cGMP-PDEs can protect heart against ischemia.

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cardiac Pacing, Artificial; Electrocardiography; Heart Ventricles; Hemodynamics; Male; Myocardial Ischemia; Purinones; Pyridines; Rabbits; Verapamil

1993